Business Context and Reporting Period
This Form 8-K Current Report was filed by Akers Biosciences, Inc. on December 2, 2015. The filing discloses the appointment of John J. Gormally as Chief Executive Officer (CEO) and the execution of a definitive employment agreement effective December 2, 2015.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation terms.
- Base Salary: $250,000 per year.
- Cash Incentive Bonus: Up to 100% of Base Salary, subject to Board discretion.
- Equity Compensation: Restricted common stock grants made bi-annually (February and August) with a 3-year vesting schedule (1/3 at grant, 1/3 at 1 year, 1/3 at 2 years).
- Equity Ranges (Annual Aggregate):
- 2016: 27,500 to 140,000 shares.
- 2017-2020: 25,000 to 125,000 shares per year.
Material Changes
The primary material change is the leadership transition with the appointment of John J. Gormally as CEO. Mr. Gormally brings over 30 years of healthcare industry experience, including senior roles at Becton, Dickinson and Company and ConvaTec. The filing incorporates the terms of his employment agreement by reference.
Guidance, Outlook, and Risks
The filing contains no financial guidance or market outlook. Key contingencies regarding the CEO's employment include:
- Termination: Either party may terminate with 30 days' written notice.
- Severance (Without Cause/Good Reason):
- Before 4 months: No severance.
- 4 months to 1 year: 1/3 of Base Salary.
- 1 year to 2 years: 1/2 of Base Salary.
- After 2 years: 1 year of Base Salary.
- Termination for Cause: No severance payable.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2013 Incentive Stock and Award Plan to assess dilution impact from the new CEO's grants.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason."
- Confirm the company's current cash position to ensure it can meet the $250,000 annual salary and potential bonus obligations.
- Check for any prior filings regarding the departure of the previous CEO to understand the full context of the leadership change.